MedTrace Logo

Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia

NCT02647892 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-08-21

No results posted yet for this study

Summary

The purpose of this study is to determine the optimal amount of lidocaine buffering needed to decrease injection pain when administering local anesthesia.

Conditions

  • Local Anesthesia

Interventions

DRUG

lidocaine

local anesthesia

DRUG

sodium bicarbonate

additional drug added to lidocaine

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Joseph McBride, MD · University of Nebraska

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-08
Primary Completion
2021-11-05
Completion
2021-11-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02647892 on ClinicalTrials.gov